Mucoadhesive formulation of Bidens pilosa L. (Asteraceae) reduces intestinal injury from 5-fluorouracil-induced mucositis in mice

Toxicology Reports - Tập 2 - Trang 563-573 - 2015
Paulo Henrique Marcelino de Ávila1, Renato Ivan de Ávila1, Edvande Xavier dos Santos Filho1, Carla Caroline Cunha Bastos1, Aline Carvalho Batista2, Elismauro Francisco Mendonça2, Raphael Caixeta Serpa3, Ricardo Neves Marreto3, Andrezza Furquim da Cruz1, Eliana Martins Lima3, Marize Campos Valadares1
1Laboratório de Farmacologia e Toxicologia Celular - FarmaTec, Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia, GO, Brazil.
2Departamento de Estomatologia, Faculdade de Odontologia, Universidade Federal de Goiás, Goiânia, GO, Brazil.
3Laboratório de Tecnologia Farmacêutica - FarmaTec, Faculdade de Farmácia, Universidade Federal de Goiás, Goiânia, GO, Brazil.

Tóm tắt

Từ khóa


Tài liệu tham khảo

Yeoh, 2007, A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-κB, COX-1, and COX-2, Mol. Cancer Ther., 6, 2319, 10.1158/1535-7163.MCT-07-0113

Han, 2011, CXCL9 attenuated chemotherapy-induced intestinal mucositis by inhibiting proliferation and reducing apoptosis, Biomed. Pharmacother., 65, 547, 10.1016/j.biopha.2011.03.008

Touchefeu, 2014, Systematic review: the role of the gut microbiota in chemotherapy-or radiation-induced gastrointestinal mucositis – current evidence and potential clinical applications, Aliment. Pharmacol. Ther., 40, 409, 10.1111/apt.12878

Tooley, 2006, A novel non-invasive biomarker for assessment of small intestinal mucositis in children with cancer undergoing chemotherapy, Cancer Biol. Ther., 5, 1275, 10.4161/cbt.5.10.3303

Azevedo, 2012, Apolipoprotein E COG 133 mimetic peptide improves 5-fluorouracil-induced intestinal mucositis, BMC Gastroenterol., 12, 35, 10.1186/1471-230X-12-35

Carneiro-Filho, 2004, Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis, Dig. Dis. Sci., 49, 65, 10.1023/B:DDAS.0000011604.45531.2c

Keefe, 2004, Gastrointestinal mucositis: a new biological model, Support. Care Cancer, 12, 6, 10.1007/s00520-003-0550-9

Lalla, 2006, Anti-inflammatory agents in the management of alimentary mucositis, Support. Care Cancer, 14, 558, 10.1007/s00520-006-0050-9

Yang, 2014, Botanical, pharmacological, phytochemical, and toxicological aspects of the antidiabetic plant Bidens pilosa L., Evid. Based Complement. Alternat. Med., 2014, 1

Abajo, 2004, In vitro study of the antioxidant and immunomodulatory activity of aqueous infusion of Bidens pilosa, J. Ethnopharmacol., 93, 319, 10.1016/j.jep.2004.03.050

Bartolome, 2013, Bidens pilosa L. (Asteraceae): botanical properties, traditional uses, phytochemistry, and pharmacology, Evid. Based Complement. Alternat. Med., 2013, 1, 10.1155/2013/340215

Borges, 2013, Bidens pilosa L. (Asteraceae): traditional use in a community of southern Brazil, Rev. Bras. Plantas Med., 15, 34, 10.1590/S1516-05722013000100004

Costa, 2008, In vitro study of mutagenic potential of Bidens pilosa Linné and Mikania glomerata Sprengel using the comet and micronucleus assays, J. Ethnopharmacol., 118, 86, 10.1016/j.jep.2008.03.014

Brandão, 1998, Two methoxylated flavone glycosides from Bidens pilosa, Phytochemistry, 48, 397, 10.1016/S0031-9422(97)01113-8

Valdés, 2001, Bidens pilosa Linné, Ver. Cubana Plant. Med., 6, 28

Alvarez, 1999, Gastric antisecretory and antiulcer activities of an ethanolic extract of Bidens pilosa L. var. radiata Schult. Bip., J. Ethnopharmacol., 67, 333, 10.1016/S0378-8741(99)00092-6

Tan, 2000, Effects of methanol, cyclohexane and methylene chloride extracts of Bidens pilosa on various gastric ulcer models in rats, J. Ethnopharmacol., 73, 415, 10.1016/S0378-8741(00)00290-7

Chih, 1996, The hepatoprotective effects of Taiwan Folk Medicine Ham-Hong-Chho in rats, Am. J. Chin. Med., 24, 231, 10.1142/S0192415X96000293

Yuan, 2008, Protective effects of total flavonoids of Bidens pilosa L. (TFB) on animal liver injury and liver fibrosis, J. Ethnopharmacol., 116, 539, 10.1016/j.jep.2008.01.010

Ubillas, 2000, Antihyperglycemic acetylenic glucosides from Bidens pilosa, Planta Med., 66, 82, 10.1055/s-0029-1243117

Jäger, 1996, Screening of Zulu medicinal plants for prostaglandin-synthesis inhibitors, J. Ethnopharmacol., 52, 95, 10.1016/0378-8741(96)01395-5

Pereira, 1999, Immunosuppressive and anti-inflammatory effects of methanolic extract and the polyacetylene isolated from Bidens pilosa L., Immunopharmacology, 43, 31, 10.1016/S0162-3109(99)00039-9

Kviecinski, 2008, Study of the antitumor potential of Bidens pilosa (Asteraceae) used in Brazilian folk medicine, J. Ethnopharmacol., 117, 69, 10.1016/j.jep.2008.01.017

Wu, 2013, Investigation of the extracts from Bidens pilosa Linn. var. radiata Sch. Bip. for antioxidant activities and cytotoxicity against human tumor cells, J. Nat. Med., 67, 17, 10.1007/s11418-012-0639-x

Rabe, 1997, Antibacterial activity of South African plants used for medicinal purposes, J. Ethnopharmacol., 56, 81, 10.1016/S0378-8741(96)01515-2

Dimo, 2002, Leaf methanol extract of Bidens pilosa prevents and attenuates the hypertension induced by high-fructose diet in Wistar rats, J. Ethnopharmacol., 83, 183, 10.1016/S0378-8741(02)00162-9

Chiang, 2004, Metabolite profiling and chemopreventive bioactivity of plant extracts from Bidens pilosa, J. Ethnopharmacol., 95, 409, 10.1016/j.jep.2004.08.010

Brandão, 1997, Antimalarial activity of extracts and fractions from Bidens pilosa and other Bidens species (Asteraceae) correlated with the presence of acetylene and flavonoid compounds, J. Ethnopharmacol., 57, 131, 10.1016/S0378-8741(97)00060-3

Oliveira, 2004, New evidences of antimalarial activity of Bidens pilosa roots extract correlated with polyacetylene and flavonoids, J. Ethnopharmacol., 93, 39, 10.1016/j.jep.2004.03.026

Chiang, 2007, Cytopiloyne, a novel polyacetylenic glucoside from Bidens pilosa, functions as a T helper cell modulator, J. Ethnopharmacol., 110, 532, 10.1016/j.jep.2006.10.007

Silva, 2011, Compilation of secondary metabolites from Bidens pilosa L., Molecules, 16, 1070, 10.3390/molecules16021070

Varum, 2008, Mucoadhesion and the gastrointestinal tract, Crit. Rev. Ther. Drug Carr. Syst., 25, 207, 10.1615/CritRevTherDrugCarrierSyst.v25.i3.10

Rossi, 2010, Thermally sensitive gels based on chitosan derivatives for the treatment of oral mucositis, Eur. J. Pharm. Biopharm., 74, 248, 10.1016/j.ejpb.2009.10.003

Desai, 2011, Development and in vitro–in vivo evaluation of fenretinide-loaded oral mucoadhesive patches for site-specific chemoprevention of oral cancer, Pharm. Res., 28, 2599, 10.1007/s11095-011-0489-3

Del Fante, 2011, Platelet lysate mucohadesive formulation to treat oral mucositis in graft versus host disease patients: a new therapeutic approach, AAPS PharmSciTech, 12, 893, 10.1208/s12249-011-9649-3

Bautzová, 2012, Bioadhesive pellets increase local 5-aminosalicylic acid concentrationin experimental colitis, Eur. J. Pharm. Biopharm., 81, 379, 10.1016/j.ejpb.2012.02.011

Ponchel, 1998, Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract, Adv. Drug Deliv. Rev., 34, 191, 10.1016/S0169-409X(98)00040-4

Dumortier, 2006, A review of poloxamer 407 pharmaceutical and pharmacological characteristics, Pharm. Res., 23, 2709, 10.1007/s11095-006-9104-4

Swain, 1999, The phenolic constituents of Prunus domestica. I. The quantitative analysis of phenolic constituents, J. Sci. Food Agric., 10, 63, 10.1002/jsfa.2740100110

Roesler, 2008, Antioxidant activity of Caryocar brasiliense (pequi) and characterization of components by electrospray ionization mass spectrometry, Food Chem., 110, 711, 10.1016/j.foodchem.2008.02.048

Hubrecht, 2010

Wu, 2010, Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-fluorouracil in a mouse mucositis model, Biomed. Pharmacother., 64, 589, 10.1016/j.biopha.2010.06.006

Lima, 2005, Effects of the tumour necrosis factor-α inhibitors pentoxifylline and thalidomide in short-term experimental oral mucositis in hamsters, Eur. J. Oral Sci., 113, 210, 10.1111/j.1600-0722.2005.00216.x

Wright, 2009, The herbal extract Iberogast® improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositis, Cancer Biol. Ther., 8, 923, 10.4161/cbt.8.10.8146

Keefe, 2000, Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans, Gut, 47, 632, 10.1136/gut.47.5.632

Chang, 2012, 5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imaging, PLoS ONE, 7, e31808, 10.1371/journal.pone.0031808

Keefe, 2007, Intestinal mucositis: mechanisms and management, Curr. Opin. Oncol., 19, 323, 10.1097/CCO.0b013e3281214412

Lee, 2014, Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation, World J. Gastroenterol., 20, 3751, 10.3748/wjg.v20.i14.3751

Shiota, 2010, Protective effects of glycoglycerolipids extracted from spinach on 5-fluorouracil induced intestinal mucosal injury, J. Med. Invest., 57, 314, 10.2152/jmi.57.314

Huang, 2009, Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model, Biochem. Biophys. Res. Commun., 389, 634, 10.1016/j.bbrc.2009.09.041

Cárdenas, 2006, Toxicological evaluation of an infusion of Bidens pilosa, Pharmacologyonline, 3, 428

Frida, 2008, In vivo and in vitro effects of Bidens pilosa L. (Asteraceae) leaf aqueous and ethanol extracts on primed-oestrogenized rat uterine muscle, Afr. J. Tradit. Complement. Altern. Med., 5, 79, 10.4314/ajtcam.v5i1.31260

Ezeonwumelu, 2011, Biochemical and histological studies of aqueous extract of Bidens pilosa leaves from Ugandan rift valley in rats, Br. J. Pharmacol. Toxicol., 2, 302

Wyllie, 2010, Where, O, death, is thy sting? A brief review of apoptosis biology, Mol. Neurobiol., 42, 4, 10.1007/s12035-010-8125-5

Galluzzi, 2015, Essential versus accessory aspects of cell death: recommendations of the NCCD 2015, Cell Death Differ., 22, 58, 10.1038/cdd.2014.137

Wong, 2011, Apoptosis in cancer: from pathogenesis to treatment, J. Exp. Clin. Cancer Res., 30, 87, 10.1186/1756-9966-30-87

Andersen, 2013, The tangled circuitry of metabolism and apoptosis, Mol. Cell, 49, 399, 10.1016/j.molcel.2012.12.026

Sonis, 2004, Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients, Cancer, 100, 1995, 10.1002/cncr.20162

Bowen, 2006, Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage, Support. Care Cancer, 14, 713, 10.1007/s00520-005-0004-7

Kanarek, 2014, Critical role for IL-1β in DNA damage-induced mucositis, Proc. Natl. Acad. Sci. U. S. A., 111, E702, 10.1073/pnas.1322691111

Gudkov, 2011, Inflammation and p53: a tale of two stresses, Genes Cancer, 2, 503, 10.1177/1947601911409747

Dowsett, 2011, Assessment of Ki67 in breast cancer: recommendations from the international Ki67 in breast cancer working group, J. Natl. Cancer Inst., 103, 1656, 10.1093/jnci/djr393

Reaves, 2005, Neutrophil transepithelial migration: role of toll-like receptors in mucosal inflammation, Mem. Inst. Oswaldo Cruz, 100, 191, 10.1590/S0074-02762005000900033

Deng, 2011, Antioxidant, analgesic, and anti-inflammatory activities of the ethanolic extracts of Taxillus liquidambaricola, J. Ethnopharmacol., 137, 1161, 10.1016/j.jep.2011.07.041

Cheah, 2009, Grape seed extract protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis, Cancer Biol. Ther., 8, 382, 10.4161/cbt.8.4.7453

Gulgun, 2010, Proanthocyanidin prevents methotrexate-induced intestinal damage and oxidative stress, Exp. Toxicol. Pathol., 62, 109, 10.1016/j.etp.2009.02.120

Kolli, 2013, Preclinical efficacy of melatonin to reduce methotrexate-induced oxidative stress and small intestinal damage in rats, Dig. Dis. Sci., 58, 959, 10.1007/s10620-012-2437-4

Yang, 2006, Protection from oxidative damage using Bidens pilosa extracts in normal human erythrocytes, Food Chem. Toxicol., 44, 1513, 10.1016/j.fct.2006.04.006